z-logo
open-access-imgOpen Access
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
Author(s) -
Ting Zhao,
Zhenyu Wang,
Yehong Chi,
Chunmei Ni,
Xudan Zheng
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10706
Subject(s) - gene knockdown , angiotensin ii , atrial natriuretic peptide , ampk , endocrinology , pressure overload , medicine , biology , brain natriuretic peptide , blot , transfection , muscle hypertrophy , pi3k/akt/mtor pathway , protein kinase a , phosphorylation , apoptosis , signal transduction , microbiology and biotechnology , heart failure , biochemistry , blood pressure , gene , cardiac hypertrophy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here